We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA released its spring unified agenda on Wednesday for upcoming proposed and final rulemakings. Here are significant planned FDA actions for drugmakers listed for the first time: